Table 2.
Pre-IPMN Extra-pancreatic Malignancy Type and Frequency.a
| All patients (72 pts, 77 tumors) |
PFH (16 pts, 17 tumors) |
NFH (56 pts, 60 tumors) |
|
|---|---|---|---|
| Breast | 16 (20.8) | 6 (35.3) | 10 (16.7) |
| Prostate | 14 (18.2) | 1 (5.9) | 13 (21.7) |
| Gynecologic | 9 (11.7) | 2 (11.8) | 7 (11.7) |
| Skin | 7 (9.1) | 3 (17.6) | 4 (6.7) |
| Bladder | 5 (6.5) | 0 (0) | 5 (8.3) |
| Colorectal | 5 (6.5) | 2 (11.8) | 3 (5.0) |
| Lymphoma/Leukemia | 5 (6.5) | 1 (5.9) | 4 (6.7) |
| Lung | 4 (5.2) | 1 (5.9) | 3 (5.0) |
| Thyroid | 2 (2.6) | 0 (0) | 2 (3.3) |
| Renal | 2 (2.6) | 1 (5.9) | 1 (1.7) |
| Other | 8 (10.4) | 0 (0) | 8 (13.3) |
a
Data presented as number of patients (percentage).